Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)
Pierre François Laterre(Université Paris-Sud), Richard S. Hotchkiss(Washington University in St. Louis), Robin Jeannet(Hôpital Universitaire Dupuytren), Christine Collienne, Bruno François(Inserm), Kenneth E. Remy(Washington University in St. Louis), Philippe Hantson(Cliniques Universitaires Saint-Luc)
Cited by 98
Related Papers
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k
The SOFA score—development, utility and challenges of accurate assessment in clinical trials
|Critical Care|2019|976
Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis
|JAMA|2003|958
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
|New England Journal of Medicine|2005|890